ARPA-H held a day-long Washington, D.C. workshop for potential applicants to its ASCENT-IBO ibogaine funding opportunity, with proposals due on 15 October.

The Advanced Research Projects Agency for Health hosted the Proposers’ Day to help prospective project teams connect and present ideas. ARPA-H expects proposals to cover clinical studies of ibogaine, ideally using a combined Phase I/II design, alongside future development plans.